Navigation Links
Cardiac stent patients with diabetes may benefit from drug that counteracts the effects of leptin
Date:12/17/2008

NEW YORK (Dec. 17, 2008) The naturally high levels of leptin in diabetic patients may reduce the effectiveness of drug-eluting stents used to treat heart blockages, but using a chemical that differs from the one commonly used to coat stents could counteract this effect.

The work by researchers at Columbia University Medical Center could potentially improve outcomes in diabetics who get stents, they say. Though drug-eluting stents reduce the chance coronary arteries will become blocked again, clogged stents are still more common in diabetic patients than in the general population. About 250,000 Americans with diabetes receive drug-eluting stents every year.

A hormone commonly associated with obesity leptin may be partly responsible, according to recently published research in the Proceedings of the National Academy of Sciences by Andrew Marks, M.D., chair of physiology & cellular biophysics and Clyde and Helen Wu Professor of Molecular Cardiology, and Steven Marx, M.D., associate professor of medicine and pharmacology. The study found that leptin, at the elevated concentrations frequently found in patients with diabetes, stimulates the growth of cells responsible for clogging the stents in mice, even in the presence of sirolimus, a drug used in many stents to prevent cell growth.

The same mouse study also identified a drug a PI3kinase inhibitor that counteracts the effect of leptin on cell growth. If added to current drug-eluting stents, such a drug may further reduce reclogging rates in patients with diabetes to the single digit rates seen in other patients. An improved stent could significantly reduce the numbers of patients who eventually need coronary bypass surgery after their stents become severely obstructed.


'/>"/>

Contact: Alex Lyda
mal2133@columbia.edu
212-305-0820
Columbia University Medical Center
Source:Eurekalert

Page: 1

Related medicine news :

1. Cost of Hospital Cardiac Care on the Rise
2. Study Asks: Are Physicians Overusing an Invasive Cardiac Treatment?
3. Hormone therapy for prostate cancer does not appear to increase cardiac deaths
4. ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software
5. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
6. Lung Disease Tied to Increased Risk for Cardiac Events
7. AGA Medical Receives European CE Mark Approval for AMPLATZER(R) Cardiac Plug
8. Another Study Warns of Risk From Cardiac Surgery Drug
9. Radiological Society of North America research: Cancer risk from cardiac CT overstated
10. Risk of death may be higher with drug commonly used during cardiac surgery
11. Large study illustrates cardiac CT can effectively assess coronary artery disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , ... February 11, 2016 , ... Dickinson Insurance & ... by announcing a new fundraiser in support of a local boy named Barrett, who ... campaign will bring awareness to, and rally support for, all local families dealing with ...
(Date:2/11/2016)... ... February 11, 2016 , ... Be Well Medical ... in the heart of Old Town at 108 South Columbus St, Suite 201, Alexandria, ... highest level of medical care in the convenience of their homes, offices or at ...
(Date:2/11/2016)... ... February 11, 2016 , ... Husted Kicking has completed its ... on February 6th & 7th, 2016 according to kicking coach Michael Husted. , “This ... to the NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third party ...
(Date:2/11/2016)... Ore. (PRWEB) , ... February 11, 2016 , ... ... Medicaid coverage results in significantly higher rates of several common cancer screenings, especially ... resulting in better outcomes and survival rates. , The study,“What Does Medicaid ...
(Date:2/10/2016)... City, California (PRWEB) , ... February 10, 2016 ... ... Imaging Society (WMIS), known as the World Molecular Imaging Congress (WMIC), will be ... theme for the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will highlight ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company ... announced today that the Company will present its operational ... Tuesday, February 16, 2016, at 4:30 p.m. ET.  The ... of its business and growth strategy, as well as ... 2015. --> --> ...
(Date:2/11/2016)... Colo. , Feb. 11, 2016  Ampio Pharmaceuticals, ... 10, 2016, it entered into a Controlled Equity Offering ... ("Cantor Fitzgerald"). Michael Macaluso , Chairman and ... stated that we are not currently raising money and ... 2016 and into 2017 and still complete all of ...
(Date:2/11/2016)... February 11, 2016 North America ... published by MarketsandMarkets, The global market is expected to reach USD ... at a CAGR of 10.2%. --> North America ... 2020", published by MarketsandMarkets, The global market is expected to reach ... growing at a CAGR of 10.2%. --> According to ...
Breaking Medicine Technology: